Robert M. Greene, PhD
, received his degree in Anatomy / Developmental Biology
from the University of Virginia and obtained postdoctoral training at the National Institutes of Health. As a professor at Jefferson Medical College in Philadelphia, he conducted NIH funded research into the Genetic and Biochemical Causes of Various Birth Defects
, including cleft lip, cleft palate, and neural tube defects such as spina bifida.
Since 1998, Dr. Greene has served as Founding Director of the University of Louisville Birth Defects Center, Chairperson of the Department of Molecular, Cellular & Craniofacial Biology, and as an Associate in the Department of Pediatrics.
Continuously funded by the NIH for the past 35 years, with over 160 peer-reviewed scientific publications, his research activities and scientific expertise encompass the genetic, epigenetic, and environmental causes of birth defects
. Dr. Greene currently serves as an Associate Editor, for the scientific journal Birth Defects Research A: Clinical & Molecular Teratology
- Dr. Greene offers expert services to attorneys for Plaintiff and Defense. He has previously served as an expert witness for the following firms: Schiller, Orborne & Barnes, Louisville, KY; Angino & Rovner, Harrisburg, PA; Collier, Shannon, Rill & Scott, Washington, D.C.
Dr. Greene's specific areas of scientific/expert witness expertise include:
View Dr. Greene's Consulting Profile
- Causes of Cleft Palate, Cleft Lip, other Craniofacial Defects
- Causes of Neural Tube Defects Responsible for such Conditions as Spina Bifida and Anencephaly
- Cigarette Smoke, and other Environmentally-induced Birth Defects and Intrauterine Growth Retardation
Issues - Plaintiff sued the city of Bloomfield, KY, claiming that contaminants, specifically trihalomethanes (THMs), in drinking water supplied by the City of Bloomfield are likely to have caused orofacial clefting deformities in children born in Bloomfield, KY in 2001.
Issues - Plaintiff sued Merrell Dow Pharmaceuticals claiming that Bendectin, an antiemetic, frequently prescribed prior to 1983 for the treatment of nausea and vomiting during pregnancy, and developed and manufactured by Merrell Dow Pharmaceuticals, caused specific birth defects in the children born to mothers treated with Bendectin.
To begin, what is the overarching mission of the University of louisville Birth Defects Center? Has this focus evolved since the Center was first established?